EL:NYSEEstee Lauder Companies, Inc. (The) Analysis
Data as of 2026-03-10 - not real-time
$95.61
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $95.61, which sits just above the 200‑day SMA of $94.00 but below the 20‑day ($105.43) and 50‑day ($109.19) averages, indicating a short‑term pullback within a longer‑term uptrend. Momentum signals are mixed: the RSI at 36 points to modest oversold pressure, while the MACD line remains bearish at –4.12 versus its signal at –2.37, producing a negative histogram. Volatility is elevated at roughly 75% over the past 30 days and beta clocks in at 1.54, suggesting the share will swing more than the market. Technical support sits near $88.17 and resistance near $117.57, giving the price a $7‑point cushion above the nearest floor. The DCF‑derived fair value of $65.02 places the current price well above intrinsic estimates, yielding an upside/downside metric of +14.7% that reflects overvaluation rather than upside potential. The Fear & Greed Index reads 80.41 (“Extreme Greed”), hinting that market sentiment may be overly bullish.
Recent earnings beat and raised guidance fuel optimism, with Q2 2026 EPS at $0.89 and a Citi upgrade to “Buy.” Conversely, HSBC downgraded the stock to “Hold,” and the dividend payout ratio of 471% of earnings raises questions about sustainability. Revenue is growing at 5.6% YoY with strong gross margins (74%), yet the company posted a negative trailing EPS and a modest ROE of –4.3%, underscoring earnings volatility. With a forward PE of 31.5 and a price‑to‑book of 8.6, the valuation leans heavily on growth expectations rather than current cash generation. Overall, the stock sits at the intersection of solid brand momentum and a stretched valuation, making it a cautious play for investors.
Recent earnings beat and raised guidance fuel optimism, with Q2 2026 EPS at $0.89 and a Citi upgrade to “Buy.” Conversely, HSBC downgraded the stock to “Hold,” and the dividend payout ratio of 471% of earnings raises questions about sustainability. Revenue is growing at 5.6% YoY with strong gross margins (74%), yet the company posted a negative trailing EPS and a modest ROE of –4.3%, underscoring earnings volatility. With a forward PE of 31.5 and a price‑to‑book of 8.6, the valuation leans heavily on growth expectations rather than current cash generation. Overall, the stock sits at the intersection of solid brand momentum and a stretched valuation, making it a cautious play for investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat and raised guidance
- Bearish MACD and elevated volatility
- Support level provides downside cushion
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Price well above DCF fair value
- High beta and volatility
- Unsustainable dividend payout
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong brand portfolio and revenue growth
- Long‑term growth premium embedded in valuation
- Potential for valuation correction
Key Metrics & Analysis
Financial Health
Revenue Growth5.60%
Profit Margin-1.21%
P/E Ratio31.5
ROE-4.34%
ROA4.42%
Debt/Equity232.94
P/B Ratio8.6
Op. Cash Flow$1.7B
Free Cash Flow$1.7B
Technical Analysis
TrendNeutral
RSI36.0
Support$88.17
Resistance$117.57
MA 20$105.43
MA 50$109.19
MA 200$94.00
MACDBearish
VolumeStable
Fear & Greed Index80.41
Valuation
Fair Value$65.02
Target Price$109.70
Upside/Downside14.73%
GradeOvervalued
TypeGrowth
Dividend Yield1.51%
Risk Assessment
Beta1.54
Volatility74.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.